Erasca (ERAS) Cash from Investing Activities Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -122.45% |
| 10 | Erasca | 4.21 Bn | 3.97 Bn | - | -811.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -811.60% |
| Dec 31, 2025 | 9.26% |
| Sep 30, 2025 | 125.05% |
| Jun 30, 2025 | 118.18% |
| Mar 31, 2025 | 243.65% |
| Dec 31, 2024 | 397.62% |
| Sep 30, 2024 | -5,561.98% |
| Jun 30, 2024 | 20.30% |
| Mar 31, 2024 | -32.23% |
| Dec 31, 2023 | 193.38% |
| Sep 30, 2023 | 96.72% |
| Jun 30, 2023 | -1,082.32% |
| Mar 31, 2023 | 920.18% |
| Dec 31, 2022 | 92.39% |
| Sep 30, 2022 | -1,018.22% |
| Jun 30, 2022 | -306.08% |
| Mar 31, 2022 | -1,007.41% |
| Dec 31, 2021 | -486.05% |
| Sep 30, 2021 | 89.95% |